RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Nervous System Trauma |
|
Accession: | DOID:9006062
|
browse the term
|
Definition: | Traumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures. |
Synonyms: | exact_synonym: | Axonotmesis; Craniocervical Injuries; Craniocervical Injury; Nervous System Injuries; Nervous System Injury; Nervous System Traumas; Neurotmeses; axonotmeses; neurotmesis |
| primary_id: | MESH:D020196 |
| xref: | EFO:0009490 |
|
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
|
IEP |
protein:increased expression:spinal cord dorsal horn (rat) |
RGD |
PMID:20079352 |
RGD:4107024 |
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10531423 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
P2rx3 |
purinergic receptor P2X 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24136739 |
|
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
IDA |
|
RGD |
PMID:15625076 |
RGD:1581125 |
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
IDA |
protein:increased phosphorylation:ganglion |
RGD |
PMID:17097800 |
RGD:1600090 |
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:23415790 |
RGD:10401075 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12503044 |
|
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
treatment |
IMP |
|
RGD |
PMID:15379997 |
RGD:329969897 |
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
|
G |
Cfl1 |
cofilin 1 |
treatment |
ISO |
|
RGD |
PMID:25708984 |
RGD:12738361 |
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IEP |
|
RGD |
PMID:26448536 |
RGD:13506960 |
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
|
IEP |
|
RGD |
PMID:26448536 |
RGD:13506960 |
NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Drd4 |
dopamine receptor D4 |
|
IEP |
|
RGD |
PMID:26448536 |
RGD:13506960 |
NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA |
|
RGD |
PMID:27113205 |
RGD:11062140 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:28140659 |
RGD:13782305 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
treatment |
IEP |
|
RGD |
PMID:28140659 |
RGD:13782305 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
treatment |
IMP |
|
RGD |
PMID:21107131 |
RGD:12791995 |
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Acan |
aggrecan |
|
IEP |
mRNA:increased expression:fascia dentata (rat) |
RGD |
PMID:18511192 |
RGD:2315807 |
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
|
|
G |
Actr2 |
actin related protein 2 |
|
IEP |
mRNA, protein:decreased expression:hippocampus (rat) |
RGD |
PMID:22120305 |
RGD:11530046 |
NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
IDA |
|
RGD |
PMID:16689670 |
RGD:2325298 |
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
|
IEP |
mRNA:increased expression:frontal cortex |
RGD |
PMID:20974230 |
RGD:5688366 |
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO IEP |
protein:increased expression:brain (rat) |
RGD |
PMID:22915134 PMID:24859607 PMID:22491548 |
RGD:7245513, RGD:8696001, RGD:7245557 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:increased expression:cerebral cortex (rat) |
RGD |
PMID:19520144 |
RGD:2313020 |
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
|
IEP |
protein:increased expression:nucleus: |
RGD |
PMID:12091479 |
RGD:10053567 |
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
IEP |
protein:increased phosphorylation:brain, neuron |
RGD |
PMID:16234845 |
RGD:5509090 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:7909931 PMID:17188501 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:14592616 |
RGD:6904155 |
NCBI chr 5:76,568,094...76,578,416
Ensembl chr 5:76,568,094...76,578,331
|
|
G |
Ank3 |
ankyrin 3 |
|
IEP |
|
RGD |
PMID:20557305 |
RGD:6767288 |
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Anp32a |
acidic nuclear phosphoprotein 32 family member A |
|
IEP |
|
RGD |
PMID:24385964 |
RGD:10401136 |
NCBI chr 8:62,829,099...62,865,443
Ensembl chr 8:62,827,456...62,865,443
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:11567033 |
RGD:2325751 |
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apbb1 |
amyloid beta precursor protein binding family B member 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:12707777 |
RGD:2301208 |
NCBI chr 1:159,896,889...159,920,505
Ensembl chr 1:159,896,880...159,920,627
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11447995 |
|
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apod |
apolipoprotein D |
|
IEP |
mRNA, protein:increased expression:cerebral cortex, glia cell, neuron |
RGD |
PMID:10501208 |
RGD:2311202 |
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
protein:increased expression:hippocampus |
RGD |
PMID:16300758 |
RGD:10054281 |
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp4 |
aquaporin 4 |
|
IEP ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:21083433 PMID:21488209 |
RGD:5148014, RGD:5148034 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Asic1 |
acid sensing ion channel subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21307247 |
|
NCBI chr 7:130,798,317...130,828,535
Ensembl chr 7:130,799,917...130,828,541
|
|
G |
Astn1 |
astrotactin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14499481 |
|
NCBI chr13:70,537,423...70,855,440
Ensembl chr13:70,537,703...70,855,440
|
|
G |
Atg12 |
autophagy related 12 |
|
IEP |
protein:altered localization:brain |
RGD |
PMID:18059433 |
RGD:2301217 |
NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
treatment |
IDA |
|
RGD |
PMID:26813465 |
RGD:13800884 |
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
|
|
G |
Avpr1a |
arginine vasopressin receptor 1A |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:17244947 |
RGD:2300372 |
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
mRNA, protein:increased expression:cerebral cortex |
RGD |
PMID:15941375 |
RGD:2292694 |
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:20888848 |
RGD:10054247 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
|
IEP |
Protein:increased expression:neurons |
RGD |
PMID:10686349 |
RGD:631308 |
NCBI chr 4:177,964,834...178,046,573
Ensembl chr 4:177,964,834...178,046,597
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IMP IEP |
|
RGD |
PMID:18093155 PMID:20888848 |
RGD:2293059, RGD:10054247 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:15500971 PMID:21269288 PMID:20544832 |
RGD:4891136 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
|
IEP ISO |
protein:increased expression:neuron, astrocyte CTD Direct Evidence: therapeutic protein:increased expression:hippocampus protein:increased expression:brain |
CTD RGD |
PMID:34929507 PMID:18500386 PMID:24221859 PMID:16874043 |
RGD:6483098, RGD:11558018, RGD:6483314 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
IEP |
mRNA, protein:increased expression:brain, astrocyte, neuron |
RGD |
PMID:15453988 |
RGD:2293136 |
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
IEP |
protein:increased expression:brain, astrocyte, neuron |
RGD |
PMID:16388909 |
RGD:2289020 |
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor type 2 |
|
IEP |
mRNA:increased expression:dentate gyrus, neuron |
RGD |
PMID:9080432 |
RGD:5129488 |
NCBI chr 9:61,192,718...61,307,280
Ensembl chr 9:61,190,566...61,301,809
|
|
G |
Bysl |
bystin-like |
|
IEP |
mRNA, protein:increased expression:substantia nigra, striatum (rat) |
RGD |
PMID:15305856 |
RGD:2316201 |
NCBI chr 9:13,382,806...13,392,557
Ensembl chr 9:13,382,557...13,394,339
|
|
G |
C1qa |
complement C1q A chain |
|
IEP |
|
RGD |
PMID:23808389 |
RGD:10054313 |
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
|
|
G |
C3 |
complement C3 |
|
IEP |
|
RGD |
PMID:23808389 |
RGD:10054313 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cask |
calcium/calmodulin dependent serine protein kinase |
|
IEP |
|
RGD |
PMID:25089700 |
RGD:11576302 |
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
|
|
G |
Casp1 |
caspase 1 |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:17188500 |
RGD:2315917 |
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
severity |
IEP |
mRNA, protein:increased expression, increased activity:cerebral cortex, hippocampus, neuron, astrocyte |
RGD |
PMID:14675152 |
RGD:2311485 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
|
RGD |
PMID:20888848 |
RGD:10054247 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
|
IEP |
protein:altered localization |
RGD |
PMID:15590916 |
RGD:1624191 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cast |
calpastatin |
severity |
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15307896 |
RGD:5509821 |
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
IEP ISO IMP |
protein:increased expression:brain, neuron CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:19210118 PMID:11113322 |
RGD:2306999, RGD:9587789 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
treatment |
IEP |
|
RGD |
PMID:22040257 |
RGD:7483630 |
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
mRNA:increased expression:hippocampus |
RGD |
PMID:24344922 |
RGD:8552265 |
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA |
|
RGD |
PMID:23924471 |
RGD:7248749 |
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
IEP IDA |
|
RGD |
PMID:11755016 PMID:25972624 |
RGD:8547803, RGD:11344972 |
NCBI chr X:135,127,052...135,138,768
Ensembl chr X:135,126,969...135,138,306
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
IEP |
protein:increased expression:nucleus: |
RGD |
PMID:9914434 |
RGD:8662346 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:decreased expression:cerebral cortex |
RGD |
PMID:21728064 |
RGD:10045359 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
mRNA, protein:increased expression:cerebral cortex (mouse) |
RGD |
PMID:19833158 |
RGD:10401206 |
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
|
ISO |
mRNA, protein:increased expression:cerebral cortex (mouse) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:19833158 |
RGD:10401206 |
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ces1d |
carboxylesterase 1D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cfb |
complement factor B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17474994 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1 |
treatment |
IEP |
|
RGD |
PMID:24252176 |
RGD:11565089 |
NCBI chr 3:108,329,859...108,335,760
Ensembl chr 3:108,330,705...108,335,758
|
|
G |
Clec4e |
C-type lectin domain family 4, member E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
IEP |
protein:increased expression:hippocampus |
RGD |
PMID:20215974 |
RGD:6483336 |
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Comt |
catechol-O-methyltransferase |
|
IEP |
protein:increased expression:hippocampus |
RGD |
PMID:17240060 |
RGD:2289740 |
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Crp |
C-reactive protein |
disease_progression |
ISO |
|
RGD |
PMID:24456846 |
RGD:9585646 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf2 |
colony stimulating factor 2 |
disease_progression |
IDA |
|
RGD |
PMID:21515263 |
RGD:5686795 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:24239694 |
RGD:11039431 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
IEP |
protein:altered expression:cerebral cortex |
RGD |
PMID:19473238 |
RGD:5686860 |
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Cul5 |
cullin 5 |
|
IEP |
mRNA, protein:decreased expression:cerebral cortex, hippocampus |
RGD |
PMID:17010517 |
RGD:2301432 |
NCBI chr 8:54,012,963...54,066,751
Ensembl chr 8:54,016,006...54,066,666
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
mRNA:increased expression:choroid plexus, cerebral cortex |
RGD |
PMID:19471279 |
RGD:5135009 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
protein:increased expression:brain, neuron |
RGD |
PMID:19210118 |
RGD:2306999 |
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
IEP |
mRNA:increased expression:hindbrain |
RGD |
PMID:16329132 |
RGD:1599699 |
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
|
IEP |
|
RGD |
PMID:18847377 |
RGD:2301705 |
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Dab2 |
DAB adaptor protein 2 |
|
IEP |
|
RGD |
PMID:15774263 |
RGD:7243841 |
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
IEP |
|
RGD |
PMID:19429151 |
RGD:9588608 |
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
IEP |
protein:increased degradation:cerebral cortex, hippocampus |
RGD |
PMID:17402852 |
RGD:2303056 |
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IDA |
|
RGD |
PMID:18509630 |
RGD:2311580 |
NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
|
IEP |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12503083 |
RGD:2317873 |
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
|
IDA |
|
RGD |
PMID:11526986 |
RGD:10395358 |
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif3e |
eukaryotic translation initiation factor 3 subunit E |
treatment |
IMP |
|
RGD |
PMID:22960363 |
RGD:10395371 |
NCBI chr 7:74,339,848...74,372,483
Ensembl chr 7:74,339,828...74,373,096
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
|
IDA |
|
RGD |
PMID:15362724 |
RGD:7488910 |
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Epas1 |
endothelial PAS domain protein 1 |
treatment |
IDA |
|
RGD |
PMID:22960363 |
RGD:10395371 |
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
|
|
G |
Epha4 |
Eph receptor A4 |
|
ISO |
protein:increased expression, increased activity:astrocyte |
RGD |
PMID:22318127 |
RGD:5688763 |
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
|
ISO |
|
RGD |
PMID:21075124 |
RGD:5688356 |
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Epo |
erythropoietin |
treatment |
ISO IEP |
CTD Direct Evidence: therapeutic mRNA:increased expression:brain: |
CTD RGD |
PMID:20833152 PMID:23063952 PMID:18093155 |
RGD:10401061, RGD:2293059 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
mRNA:increased expression:brain: |
RGD |
PMID:18093155 |
RGD:2293059 |
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
F2 |
coagulation factor II, thrombin |
severity |
ISO |
|
RGD |
PMID:21355766 |
RGD:5147766 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP ISO |
mRNA:increased expression:hippocampus associated with Hyperoxia |
RGD |
PMID:16078565 PMID:19107989 |
RGD:1600354, RGD:8662854 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21269288 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IEP |
protein:altered localization:hippocampus (rat) |
RGD |
PMID:16510718 |
RGD:11667962 |
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9630518 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxp1 |
forkhead box P1 |
treatment |
IDA |
|
RGD |
PMID:26842647 |
RGD:11561903 |
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
IEP |
protein:decreased expression:hippocampus |
RGD |
PMID:18501200 |
RGD:2307353 |
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
|
|
G |
Gabrg3 |
gamma-aminobutyric acid type A receptor subunit gamma 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:18501516 |
RGD:2324932 |
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
treatment |
IEP |
|
RGD |
PMID:23485053 |
RGD:8662424 |
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
|
IEP |
protein:increased expression:cerebral artery |
RGD |
PMID:21895483 |
RGD:7207391 |
NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
IEP |
mRNA:decreased expression:hippocampus, neuron |
RGD |
PMID:15791111 |
RGD:2306624 |
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grm8 |
glutamate metabotropic receptor 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:24675465 PMID:22643085 |
RGD:10045646 |
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
|
IEP |
|
RGD |
PMID:14588109 |
RGD:1599864 |
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Hcn1 |
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 |
|
IEP |
mRNA,protein:decreased expression:hippocampus: |
RGD |
PMID:11726545 |
RGD:9686434 |
NCBI chr 2:49,495,771...49,899,983
Ensembl chr 2:49,495,771...49,899,774
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
IMP |
|
RGD |
PMID:22915134 |
RGD:7245513 |
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
IMP |
|
RGD |
PMID:18562561 |
RGD:5508455 |
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
|
RGD |
PMID:23470432 |
RGD:10755702 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp |
haptoglobin |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:23172820 |
RGD:11041806 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:21549006 |
RGD:5147593 |
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
|
IEP |
protein:increased expression:cerebral white matter (rat) |
RGD |
PMID:22067617 |
RGD:5688785 |
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
|
IEP |
|
RGD |
PMID:11746764 |
RGD:6480530 |
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
|
IMP |
|
RGD |
PMID:22465320 |
RGD:6482178 |
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
protein:increased expression:brain: |
RGD |
PMID:16230799 |
RGD:11522716 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifnl3 |
interferon, lambda 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Igf1 |
insulin-like growth factor 1 |
treatment |
ISO |
human protein in a rat model |
RGD |
PMID:9344566 |
RGD:12904928 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
IEP |
mRNA:decreased expression:brain |
RGD |
PMID:11123717 |
RGD:5509972 |
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Il10 |
interleukin 10 |
severity treatment |
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:23075771 PMID:23971414 |
RGD:7364822, RGD:7364983 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12rb2 |
interleukin 12 receptor subunit beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:96,426,396...96,515,251
Ensembl chr 4:96,426,842...96,515,289
|
|
G |
Il13ra2 |
interleukin 13 receptor subunit alpha 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr X:111,002,590...111,074,053
Ensembl chr X:111,002,592...111,072,381
|
|
G |
Il16 |
interleukin 16 |
|
IEP |
|
RGD |
PMID:17983426 |
RGD:5024939 |
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il17rd |
interleukin 17 receptor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Il18 |
interleukin 18 |
severity |
IMP ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:17188500 PMID:17188500 |
RGD:2315917, RGD:2315917 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il18r1 |
interleukin 18 receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP ISO |
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:16024175 |
RGD:2311098 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
|
IEP ISO |
mRNA, protein:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism protein:increased expression:brain, cerebrospinal fluid mRNA, protein:increased expression:brain |
CTD RGD |
PMID:19800810 PMID:21549006 PMID:16024175 PMID:22503903 PMID:17612572 |
RGD:2311098, RGD:6482651, RGD:1626652 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:25665855 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il3 |
interleukin 3 |
disease_progression |
IDA ISO |
protein: increased expression: brain: microdialysis perfusate |
RGD |
PMID:21515263 PMID:20717122 |
RGD:5686795, RGD:5686886 |
NCBI chr10:38,405,716...38,408,066
Ensembl chr10:38,405,716...38,408,066
|
|
G |
Il31ra |
interleukin 31 receptor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:44,118,748...44,189,943
Ensembl chr 2:44,122,624...44,183,767
|
|
G |
Il4 |
interleukin 4 |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:24519543 |
RGD:10402802 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
treatment |
IEP |
|
RGD |
PMID:24602693 PMID:24530657 |
RGD:11522766, RGD:11522770 |
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
|
IEP ISO |
protein:increased expression:cerebrospinal fluid (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19800810 PMID:21549006 PMID:23159883 PMID:10027774 |
RGD:11049549 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7 |
interleukin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:94,235,219...94,280,075
Ensembl chr 2:94,234,766...94,280,075
|
|
G |
Il9r |
interleukin 9 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,431,706...15,441,990
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IEP ISO |
mRNA:increased expression:cerebral cortex CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:12503083 |
RGD:2317873 |
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Jak2 |
Janus kinase 2 |
|
IMP |
|
RGD |
PMID:21596098 |
RGD:6483023 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
|
IEP |
|
RGD |
PMID:20861444 |
RGD:8662901 |
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP IMP |
protein:increased expression:cerebral cortex |
RGD |
PMID:21307798 PMID:19733172 |
RGD:5684382, RGD:5684402 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Lep |
leptin |
|
IEP |
|
RGD |
PMID:21276361 |
RGD:5128517 |
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lsg1 |
large 60S subunit nuclear export GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:14499481 |
|
NCBI chr11:70,132,919...70,168,526
Ensembl chr11:70,143,847...70,168,518
|
|
G |
Ly86 |
lymphocyte antigen 86 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
|
|
G |
Mag |
myelin-associated glycoprotein |
susceptibility |
IMP |
|
RGD |
PMID:17156367 |
RGD:9685230 |
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Map1b |
microtubule-associated protein 1B |
|
IEP |
protein:increased expression, increased phosphorylation:brain |
RGD |
PMID:10906717 |
RGD:2304029 |
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
|
IEP |
|
RGD |
PMID:24221859 |
RGD:11558018 |
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Map2 |
microtubule-associated protein 2 |
|
IEP IDA |
protein:decreased expression:cerebral cortex, neuron |
RGD |
PMID:21401443 PMID:20568963 |
RGD:6483087, RGD:6483089 |
NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809
|
|
G |
Map3k7 |
mitogen activated protein kinase kinase kinase 7 |
treatment |
IEP ISO IMP |
associated with Subarachnoid Hemorrhage |
RGD |
PMID:27000704 PMID:33414375 PMID:26100626 |
RGD:155791672, RGD:155882440, RGD:155804286 |
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
|
|
G |
Mbl2 |
mannose binding lectin 2 |
disease_progression |
ISO |
|
RGD |
PMID:18183030 |
RGD:12910935 |
NCBI chr 1:228,016,439...228,024,736
|
|
G |
Mbp |
myelin basic protein |
|
IDA |
|
RGD |
PMID:18583256 |
RGD:7349333 |
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
|
IEP |
protein:increased expression:brain cortex (rat) |
RGD |
PMID:15165363 |
RGD:2317397 |
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
IEP |
|
RGD |
PMID:15922484 |
RGD:1641989 |
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
|
|
G |
Mir132 |
microRNA 132 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:60,023,696...60,023,796
Ensembl chr10:60,023,696...60,023,796
|
|
G |
Mir144 |
microRNA 144 |
|
IEP |
|
RGD |
PMID:25089700 |
RGD:11576302 |
NCBI chr10:62,961,348...62,961,430
Ensembl chr10:62,961,348...62,961,430
|
|
G |
Mir153 |
microRNA 153 |
|
IEP |
|
RGD |
PMID:25089700 |
RGD:11576302 |
NCBI chr 6:138,163,595...138,163,681
Ensembl chr 6:138,163,595...138,163,681
|
|
G |
Mir183 |
microRNA 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
IDA IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19631748 PMID:16671440 PMID:24661104 |
RGD:1582656, RGD:13207312 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
IEP |
mRNA, protein:increased expression:hippocampus |
RGD |
PMID:11686499 |
RGD:2302298 |
NCBI chr MT:7,006...7,689
Ensembl chr MT:7,006...7,689
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO IEP |
mRNA:increased expression:liver (mouse) mRNA:increased expression:dentate gyrus (rat) |
RGD |
PMID:22363575 PMID:15650329 |
RGD:6483812, RGD:6483847 |
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
treatment |
IDA IEP |
|
RGD |
PMID:16314047 PMID:10595827 PMID:10218634 |
RGD:6480628, RGD:9685805, RGD:9685803 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Myoc |
myocilin |
|
IEP |
mRNA:increased expression:cerebral cortex (rat) |
RGD |
PMID:12799138 |
RGD:7401267 |
NCBI chr13:74,976,730...74,987,128
Ensembl chr13:74,976,730...74,987,127
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
IEP |
protein:increased expression:lung: |
RGD |
PMID:18787991 PMID:25089700 |
RGD:5134971, RGD:11576302 |
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ngb |
neuroglobin |
severity |
IEP |
|
RGD |
PMID:21915648 |
RGD:9743963 |
NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830
|
|
G |
Ngfr |
nerve growth factor receptor |
treatment |
IDA |
|
RGD |
PMID:23940017 |
RGD:10414074 |
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP |
|
RGD |
PMID:11526986 |
RGD:10395358 |
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
associated with lung diseases;protein:increased expression:serum: CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:19803787 PMID:23837838 |
RGD:7247620 |
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Npy |
neuropeptide Y |
|
IEP |
protein:increased expression:adrenal medulla |
RGD |
PMID:23570732 |
RGD:10448961 |
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
IEP |
mRNA:increased expression:lung associated with Subarachnoid Hemorrhage |
RGD |
PMID:18787991 PMID:20864352 |
RGD:5134971, RGD:11035222 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nt5e |
5' nucleotidase, ecto |
|
IEP |
protein:altered expression:cerebral cortex (rat) |
RGD |
PMID:21337375 |
RGD:5134348 |
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
|
|
G |
P2ry1 |
purinergic receptor P2Y1 |
|
IEP |
protein:increased expression:brain, astrocyte |
RGD |
PMID:19115395 |
RGD:2315811 |
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
|
|
G |
Palld |
palladin, cytoskeletal associated protein |
|
IEP |
protein:increased expression:brain, astrocyte |
RGD |
PMID:12932445 |
RGD:2325786 |
NCBI chr16:28,228,006...28,621,349
Ensembl chr16:27,981,354...28,621,337
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17640816 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
IEP |
mRNA,protein:increased expression:brain: |
RGD |
PMID:11421591 |
RGD:9835358 |
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pde4d |
phosphodiesterase 4D |
|
IEP |
mRNA, protein:alternative form, decreased phosphorylation:brain |
RGD |
PMID:23057870 |
RGD:7327147 |
NCBI chr 2:40,014,933...41,529,190
Ensembl chr 2:40,019,933...41,525,884
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
|
IEP |
mRNA:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:9645955 |
RGD:11084932 |
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IDA |
|
RGD |
PMID:22658532 |
RGD:6484732 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 1:78,531,815...78,537,001
Ensembl chr 1:78,531,815...78,537,001
|
|
G |
Pgr |
progesterone receptor |
|
IEP |
|
RGD |
PMID:23211561 |
RGD:7248711 |
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Phb1 |
prohibitin 1 |
|
IEP |
protein:increased oxidation:cerebral cortex |
RGD |
PMID:17518533 |
RGD:2292409 |
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Phb2 |
prohibitin 2 |
|
IEP |
|
RGD |
PMID:24566151 |
RGD:12903261 |
NCBI chr 4:157,517,662...157,522,268
Ensembl chr 4:157,517,577...157,522,272
|
|
G |
Pias1 |
protein inhibitor of activated STAT, 1 |
|
IEP |
protein:decreased expression:brain, nucleus |
RGD |
PMID:21545521 |
RGD:8693413 |
NCBI chr 8:63,338,150...63,451,670
Ensembl chr 8:63,338,150...63,438,905
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
IDA |
agonist more effective in combination with simvastatin |
RGD |
PMID:18562561 |
RGD:5508455 |
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
ISO IEP |
protein:decreased expression:frontal cortex (rat) |
RGD |
PMID:22642418 PMID:24345766 |
RGD:6484257, RGD:10059630 |
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
|
IEP ISO |
protein: :hippocampus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14499481 PMID:19751097 |
RGD:6483311 |
NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974
|
|
G |
Prf1 |
perforin 1 |
|
ISO |
|
RGD |
PMID:20537642 |
RGD:6482807 |
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
|
IEP |
protein:increased expression:striatum, microglia (rat) |
RGD |
PMID:15234107 |
RGD:9850280 |
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO IEP |
protein:increased expression:microglia, macrophage protein:increased expression:microglial cells, macrophage, endothelial cell |
RGD |
PMID:19719848 PMID:11565600 PMID:12005397 |
RGD:5688162, RGD:5688242, RGD:5688239 |
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12410334 PMID:20810888 PMID:21549006 PMID:21866634 PMID:19719848 |
RGD:5508191, RGD:5688162 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z1 |
|
IEP |
|
RGD |
PMID:12088737 |
RGD:727637 |
NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:51,397,601...51,595,218
|
|
G |
Rchy1 |
ring finger and CHY zinc finger domain containing 1 |
|
IEP |
protein:increased expression:cerebral cortex |
RGD |
PMID:21728064 |
RGD:10045359 |
NCBI chr14:16,113,263...16,129,017
Ensembl chr14:16,113,224...16,129,167
|
|
G |
Reg3b |
regenerating family member 3 beta |
|
IEP |
mRNA:increased expression:cerebral cortex (rat) |
RGD |
PMID:19351265 |
RGD:9831399 |
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
IEP |
protein:increased expression:ileum |
RGD |
PMID:18288455 |
RGD:2298787 |
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ret |
ret proto-oncogene |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:18501516 |
RGD:2324932 |
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Rhoa |
ras homolog family member A |
|
IEP |
protein:increased expression:microglial cell, brain |
RGD |
PMID:17929039 |
RGD:2298888 |
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
IEP |
mRNA:increased expression:brain protein:increased expression:brain, immune cell |
RGD |
PMID:16262652 PMID:26550694 |
RGD:2316136, RGD:243048437 |
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr11:12,528,949...14,096,726
Ensembl chr11:12,528,951...13,041,536
|
|
G |
Robo3 |
roundabout guidance receptor 3 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr 8:37,133,542...37,151,674
Ensembl chr 8:37,133,916...37,151,315
|
|
G |
Rps27a |
ribosomal protein S27a |
|
IEP |
mRNA:decreased expression:cerebral cortex, hippocampus |
RGD |
PMID:17936732 |
RGD:11041870 |
NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 Ensembl chr 5:103,285,734...103,288,011
|
|
G |
S100b |
S100 calcium binding protein B |
severity |
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD RGD |
PMID:11520488 PMID:21783483 PMID:21976236 |
RGD:5508761 |
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sele |
selectin E |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19107536 |
RGD:2313599 |
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Serpinc1 |
serpin family C member 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:21534203 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
G |
Serpinf1 |
serpin family F member 1 |
treatment |
ISO IEP |
human gene in a rat model protein:altered expression:cerebellum (rat) |
RGD |
PMID:20142768 PMID:17709187 |
RGD:8612994, RGD:8622925 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
|
RGD |
PMID:17970622 |
RGD:9497541 |
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Skp2 |
S-phase kinase associated protein 2 |
|
IEP |
protein:increased expression:brain |
RGD |
PMID:19852587 |
RGD:2315049 |
NCBI chr 2:58,161,226...58,189,293
Ensembl chr 2:58,161,229...58,189,338
|
|
G |
Slc18a3 |
solute carrier family 18 member A3 |
|
IEP |
protein:decreased expression:brain |
RGD |
PMID:18848922 |
RGD:5686682 |
NCBI chr16:7,713,630...7,716,491
|
|
G |
Slit1 |
slit guidance ligand 1 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr 1:240,409,559...240,558,127
Ensembl chr 1:240,409,561...240,558,127
|
|
G |
Slit2 |
slit guidance ligand 2 |
exacerbates |
IMP |
|
RGD |
PMID:26550694 |
RGD:243048437 |
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
|
|
G |
Slit3 |
slit guidance ligand 3 |
|
IEP |
mRNA:increased expression:brain |
RGD |
PMID:16262652 |
RGD:2316136 |
NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
|
|
G |
Snca |
synuclein alpha |
|
ISO IEP |
|
RGD |
PMID:14637093 PMID:25089700 |
RGD:6480195, RGD:11576302 |
NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262
|
|
G |
Sncb |
synuclein, beta |
|
ISO |
|
RGD |
PMID:14637093 |
RGD:6480195 |
NCBI chr17:9,846,802...9,855,013
Ensembl chr17:9,846,802...9,855,012
|
|
G |
Sncg |
synuclein, gamma |
|
ISO |
|
RGD |
PMID:14637093 |
RGD:6480195 |
NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368
|
|
G |
Snw1 |
SNW domain containing 1 |
|
IEP |
mRNA, protein:increased expression:cerebral cortex (rat) |
RGD |
PMID:22965216 |
RGD:11035237 |
NCBI chr 6:107,095,450...107,119,536
Ensembl chr 6:107,095,457...107,119,536
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
|
RGD |
PMID:16248885 |
RGD:1581214 |
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:24462953 PMID:16248885 |
RGD:1581214 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
IEP |
mRNA:increased expression:brain, blood vessel |
RGD |
PMID:9704602 |
RGD:2300066 |
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
|
|
G |
Sstr2 |
somatostatin receptor 2 |
|
IEP |
|
RGD |
PMID:11879809 |
RGD:2325002 |
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
|
|
G |
Sstr3 |
somatostatin receptor 3 |
|
IEP |
|
RGD |
PMID:11879809 |
RGD:2325002 |
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
|
|
G |
Sstr4 |
somatostatin receptor 4 |
|
IEP |
|
RGD |
PMID:11879809 |
RGD:2325002 |
NCBI chr 3:135,854,826...135,856,689
Ensembl chr 3:135,854,826...135,856,689
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
IMP |
|
RGD |
PMID:21596098 |
RGD:6483023 |
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
IMP IDA |
protein:increased phosphorylation:brain |
RGD |
PMID:21596098 PMID:22145815 PMID:22827467 |
RGD:6483023, RGD:8694312, RGD:6892706 |
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Strn |
striatin |
|
IEP |
|
RGD |
PMID:16351572 |
RGD:2311293 |
NCBI chr 6:16,335,265...16,422,159
Ensembl chr 6:16,335,358...16,417,083
|
|
G |
Tardbp |
TAR DNA binding protein |
|
ISO |
|
RGD |
PMID:22101322 |
RGD:5687195 |
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
G |
Tf |
transferrin |
|
IEP |
|
RGD |
PMID:22538758 |
RGD:7244386 |
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Th |
tyrosine hydroxylase |
|
IEP |
protein:decreased activity:striatum (rat) |
RGD |
PMID:21047500 |
RGD:5128822 |
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Thbd |
thrombomodulin |
onset |
ISO |
|
RGD |
PMID:17895610 |
RGD:5685007 |
NCBI chr 3:135,863,366...135,867,018
Ensembl chr 3:135,862,835...135,867,193
|
|
G |
Ticam2 |
TIR domain containing adaptor molecule 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr18:39,289,902...39,311,462
Ensembl chr18:39,294,453...39,311,462
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
IEP |
mRNA:increased expression:brain, astrocytes |
RGD |
PMID:10719361 |
RGD:2290468 |
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
IEP |
mRNA:increased expression:brain, neuron, microglial cell |
RGD |
PMID:10719361 |
RGD:2290468 |
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tjp1 |
tight junction protein 1 |
|
IEP |
|
RGD |
PMID:19889224 |
RGD:2325128 |
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Tlr1 |
toll-like receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IEP ISO |
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:18316784 |
RGD:2312713 |
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
IEP ISO |
mRNA:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:18316784 |
RGD:2312713 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21549006 |
|
NCBI chr 8:106,864,680...106,868,796
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO IMP |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19800810 PMID:21549006 PMID:10674461 |
RGD:13825262 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf13b |
TNF receptor superfamily member 13B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:45,801,860...45,824,932
Ensembl chr10:45,801,860...45,822,987
|
|
G |
Tnfrsf13c |
TNF receptor superfamily member 13C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 7:113,736,046...113,738,523
Ensembl chr 7:113,736,055...113,738,517
|
|
G |
Tnfrsf14 |
TNF receptor superfamily member 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 5:165,486,069...165,494,421
Ensembl chr 5:165,484,262...165,493,703
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP ISO |
protein:increased expression:brain CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21549006 PMID:17074049 |
RGD:1624183 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnfsf12 |
TNF superfamily member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:54,403,870...54,413,213
Ensembl chr10:54,403,870...54,413,213
|
|
G |
Traf4 |
Tnf receptor associated factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23159883 |
|
NCBI chr10:63,054,169...63,060,284
Ensembl chr10:63,054,181...63,060,284
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
|
IEP |
mRNA, protein:increased expression:cerebral cortex, hippocampus |
RGD |
PMID:20309649 |
RGD:9999437 |
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
|
|
G |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
IEP |
mRNA:decreased expression:cerebral cortex, hippocampus (rat) |
RGD |
PMID:17936732 |
RGD:11041870 |
NCBI chr16:18,918,614...18,920,807
Ensembl chr16:18,900,616...18,920,807
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:12858170 PMID:12858170 |
RGD:7204436 |
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
IEP ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:18065154 PMID:12230324 |
RGD:1580574 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfb |
vascular endothelial growth factor B |
|
IEP |
mRNA, protein:increased expression:brain |
RGD |
PMID:12230324 |
RGD:1580574 |
NCBI chr 1:204,172,297...204,178,046
Ensembl chr 1:204,172,225...204,177,944
|
|
G |
Vim |
vimentin |
|
ISO IEP |
protein:increased expression:brain |
RGD |
PMID:19728994 PMID:15527750 |
RGD:6480519, RGD:6480527 |
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:26528358 |
RGD:13208950 |
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
ClinVar Annotator: match by term: Carotid artery dissection |
ClinVar |
PMID:1301956 PMID:2088165 PMID:2318961 PMID:3263645 PMID:8882879 PMID:9157944 PMID:9484998 PMID:10782930 PMID:10978268 PMID:12837857 PMID:16183066 PMID:16250003 PMID:17094996 PMID:17765246 PMID:18677035 PMID:19318025 PMID:20506408 PMID:21310417 PMID:21475731 PMID:21722902 PMID:22390909 PMID:22698793 PMID:23375686 PMID:24033266 PMID:25741868 PMID:27765764 PMID:28492532 PMID:29261184 PMID:29399563 PMID:31345425 More...
|
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
ClinVar Annotator: match by term: Carotid artery dissection |
ClinVar |
PMID:25326637 PMID:25741868 PMID:28492532 PMID:30755392 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
ClinVar Annotator: match by term: Internal carotid artery dissection |
ClinVar |
PMID:1301956 PMID:2088165 PMID:2318961 PMID:3263645 PMID:8882879 PMID:9157944 PMID:9484998 PMID:10782930 PMID:10978268 PMID:12837857 PMID:16183066 PMID:16250003 PMID:17094996 PMID:17765246 PMID:18677035 PMID:19318025 PMID:20506408 PMID:21310417 PMID:21475731 PMID:21722902 PMID:22390909 PMID:22698793 PMID:23375686 PMID:24033266 PMID:25741868 PMID:27765764 PMID:28492532 PMID:29261184 PMID:29399563 PMID:31345425 More...
|
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mylk |
myosin light chain kinase |
|
ISO |
ClinVar Annotator: match by term: Internal carotid artery dissection |
ClinVar |
PMID:25326637 PMID:25741868 PMID:28492532 PMID:30755392 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
protein:decreased expression:vascular smooth muscle cell carotid artery (mouse) |
RGD |
PMID:25751394 |
RGD:329328927 |
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Acvr1 |
activin A receptor type 1 |
|
IEP |
mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 3:42,978,558...43,097,892
Ensembl chr 3:42,978,561...43,098,241
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IMP |
|
RGD |
PMID:21680901 |
RGD:7245963 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
treatment |
IEP |
mRNA:increased expression:artery: |
RGD |
PMID:9918604 |
RGD:10047106 |
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
IEP |
|
RGD |
PMID:16118253 |
RGD:5509614 |
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Carmn |
cardiac mesoderm enhancer-associated non-coding RNA |
|
IEP |
mRNA:decreased expression:carotid artery: |
RGD |
PMID:34694145 |
RGD:155883160 |
NCBI chr18:55,097,848...55,118,769
Ensembl chr18:55,095,230...55,118,825
|
|
G |
Cbl |
Cbl proto-oncogene |
|
IEP |
protein:hyperphosphorylation:tyrosine: |
RGD |
PMID:18663086 |
RGD:11038825 |
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO IDA |
human gene in rat model |
RGD |
PMID:12223446 PMID:15353495 |
RGD:8549774, RGD:11526152 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
IEP |
protein:increased expression:arterial wall (rat) |
RGD |
PMID:19570811 |
RGD:2314490 |
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccna2 |
cyclin A2 |
|
IEP |
mRNA:increased expression:artery: |
RGD |
PMID:18667424 |
RGD:10054494 |
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
disease_progression |
IEP |
|
RGD |
PMID:10623660 |
RGD:11341688 |
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
IEP |
mRNA, protein:increased expression: carotid artery endothelium (rat) |
RGD |
PMID:27135205 |
RGD:151665776 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
IEP |
protein:increased expression:smooth muscle cell: |
RGD |
PMID:15385271 |
RGD:11039423 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
|
IEP |
|
RGD |
PMID:9546380 |
RGD:7771579 |
NCBI chr10:16,680,478...16,683,275
|
|
G |
Foxo3 |
forkhead box O3 |
|
IEP |
|
RGD |
PMID:15662024 |
RGD:10402197 |
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Gc |
GC, vitamin D binding protein |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:21416056 |
RGD:5509868 |
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Gp6 |
glycoprotein VI |
treatment |
ISO |
human protein in a mouse model |
RGD |
PMID:18566102 |
RGD:401824643 |
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
ameliorates |
IEP |
|
RGD |
PMID:34487706 |
RGD:156430326 |
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
IEP |
protein:increased expression:carotid artery: |
RGD |
PMID:19389706 |
RGD:9681448 |
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
|
IEP |
|
RGD |
PMID:11971902 |
RGD:625426 |
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hey2 |
hes-related family bHLH transcription factor with YRPW motif 2 |
|
IEP |
|
RGD |
PMID:11971902 |
RGD:625426 |
NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218
|
|
G |
Heyl |
hes-related family bHLH transcription factor with YRPW motif-like |
|
IEP |
|
RGD |
PMID:11971902 |
RGD:625426 |
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152
|
|
G |
Hp |
haptoglobin |
|
IEP |
|
RGD |
PMID:19012726 |
RGD:11041814 |
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
mRNA:increased expression:carotid artery (rat) |
RGD |
PMID:20368503 |
RGD:4145429 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
protein:increased expression:serum,carotid artery: |
RGD |
PMID:12490968 |
RGD:10046051 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
treatment |
IEP |
protein:increased phosphorylation:carotid artery: |
RGD |
PMID:17606126 |
RGD:10046006 |
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Il18 |
interleukin 18 |
|
IMP IEP |
protein:increased expression:carotid artery |
RGD |
PMID:16864728 PMID:19955748 |
RGD:4889500, RGD:4889159 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
human gene in rat model |
RGD |
PMID:12754378 |
RGD:2316108 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Itgav |
integrin subunit alpha V |
|
IEP |
mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Itgb3 |
integrin subunit beta 3 |
|
IEP |
protein:increased expression:carotid artery mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:17868879 PMID:9622270 |
RGD:4892652, RGD:329845558 |
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
IEP |
protein:increased expression:carotid artery |
RGD |
PMID:21330605 |
RGD:6482230 |
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Klf4 |
KLF transcription factor 4 |
ameliorates |
IMP |
|
RGD |
PMID:29127880 |
RGD:155230825 |
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
IEP |
protein:increased activity:carotid artery: |
RGD |
PMID:14638553 |
RGD:10412321 |
NCBI chr 1:14,685,776...14,904,935
Ensembl chr 1:14,685,492...14,904,800
|
|
G |
Mir145 |
microRNA 145 |
|
IEP |
miRNA:altered expression:wall of blood vessel (rat) |
RGD |
PMID:19542014 |
RGD:13210556 |
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir223 |
microRNA 223 |
|
IEP |
RNA:increased expression:carotid artery |
RGD |
PMID:26065992 |
RGD:25824846 |
NCBI chr X:61,141,887...61,141,996
Ensembl chr X:61,141,887...61,141,996
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IEP |
|
RGD |
PMID:9327785 |
RGD:8547910 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
IEP |
|
RGD |
PMID:9327785 |
RGD:8547910 |
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
|
RGD |
PMID:9327785 |
RGD:8547910 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment |
IDA IMP IEP |
mRNA:increased expression:carotid artery (rat) |
RGD |
PMID:23178522 PMID:8113414 PMID:22546228 |
RGD:7207861, RGD:10059612, RGD:7240535 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
IEP |
protein:increased expression:carotid artery: |
RGD |
PMID:11003588 |
RGD:11533926 |
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
|
|
G |
Nono |
non-POU domain containing, octamer-binding |
ameliorates |
ISO |
|
RGD |
PMID:33626912 |
RGD:155900763 |
NCBI chr X:66,554,131...66,571,992
Ensembl chr X:66,554,098...66,571,952
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:29207649 |
RGD:13504723 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Notch1 |
notch receptor 1 |
|
IEP |
|
RGD |
PMID:11971902 |
RGD:625426 |
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch2 |
notch receptor 2 |
|
IEP |
|
RGD |
PMID:11971902 |
RGD:625426 |
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Notch3 |
notch receptor 3 |
|
IEP |
|
RGD |
PMID:11971902 |
RGD:625426 |
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
IEP |
protein:increased expression:blood vessel: |
RGD |
PMID:15044192 |
RGD:10413907 |
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
|
ISO |
protein:increased expression:vascular smooth muscle cell carotid artery (mouse) |
RGD |
PMID:25751394 |
RGD:329328927 |
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pcsk5 |
proprotein convertase subtilisin/kexin type 5 |
|
IEP |
mRNA,protein:increased expression:artery: |
RGD |
PMID:12649739 |
RGD:11556213 |
NCBI chr 1:214,837,847...215,267,626
Ensembl chr 1:214,837,927...215,267,600
|
|
G |
Pdgfd |
platelet derived growth factor D |
|
IEP |
protein:increased expression:carotid artery: |
RGD |
PMID:18258854 |
RGD:9854624 |
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
|
|
G |
Plat |
plasminogen activator, tissue type |
|
IEP |
mRNA, protein:increased expression, increased activity:carotid artery (rat) |
RGD |
PMID:8343497 |
RGD:11537479 |
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Postn |
periostin |
|
IEP |
mRNA,protein:increased expression:artery: |
RGD |
PMID:15514205 |
RGD:10040973 |
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
treatment |
ISO |
mouse gene in a rat model |
RGD |
PMID:19339015 |
RGD:8553019 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
IDA ISO |
mouse gene in a rat model |
RGD |
PMID:22892143 PMID:19553562 |
RGD:7242065, RGD:2311405 |
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
IEP |
protein:increased expression:aorta tunica intima, aorta tunica media |
RGD |
PMID:12117720 |
RGD:39456082 |
NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
|
IEP |
protein:increased expression:carotid artery, intima (rat) |
RGD |
PMID:24988324 |
RGD:9835414 |
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
|
|
G |
Robo1 |
roundabout guidance receptor 1 |
|
IEP |
mRNA:increased expression:carotid artery |
RGD |
PMID:26841069 |
RGD:243048443 |
NCBI chr11:10,580,863...11,621,675
Ensembl chr11:10,580,908...11,620,203
|
|
G |
Scgb1a1 |
secretoglobin family 1A member 1 |
|
IDA |
|
RGD |
PMID:11107082 |
RGD:5144055 |
NCBI chr 1:205,977,060...205,980,610
Ensembl chr 1:205,977,060...205,980,610
|
|
G |
Serpine1 |
serpin family E member 1 |
|
IEP |
mRNA:increased expression:carotid artery (rat) |
RGD |
PMID:25617690 |
RGD:11075082 |
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Serpinf1 |
serpin family F member 1 |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:17525281 |
RGD:8618841 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Slit2 |
slit guidance ligand 2 |
|
IEP |
mRNA:increased expression:carotid artery |
RGD |
PMID:26841069 |
RGD:243048443 |
NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
|
|
G |
Sp1 |
Sp1 transcription factor |
|
IEP |
protein:increased phosphorylation:smooth muscle cell: |
RGD |
PMID:18258854 |
RGD:9854624 |
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Spon2 |
spondin 2 |
|
ISO |
protein:decreased expression:vascular smooth muscle cell carotid artery (mouse) |
RGD |
PMID:25751394 |
RGD:329328927 |
NCBI chr14:77,505,695...77,518,001
Ensembl chr14:77,511,901...77,517,996
|
|
G |
Tagln |
transgelin |
|
IEP |
mRNA:decreased expression:carotid artery: |
RGD |
PMID:34694145 |
RGD:155883160 |
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
IEP |
mRNA,protein:increased expression:carotid artery: |
RGD |
PMID:20537494 |
RGD:11060271 |
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
IEP |
mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
|
IEP |
mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
IEP |
mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
IEP |
mRNA:increased expression:carotic artery (rat) |
RGD |
PMID:9622270 |
RGD:329845558 |
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
|
G |
Phactr1 |
phosphatase and actin regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25420145 |
|
NCBI chr17:21,560,364...22,040,166
Ensembl chr17:21,562,721...22,039,831
|
|
|
G |
Apoe |
apolipoprotein E |
susceptibility |
ISO |
DNA:polymorphism:exon: |
RGD |
PMID:9214529 |
RGD:7495763 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Tardbp |
TAR DNA binding protein |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:20720505 |
RGD:5687179 |
NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:159,051,799...159,062,055
|
|
|
G |
Becn1 |
beclin 1 |
|
ISO |
protein:increased expression:neuron |
RGD |
PMID:16004578 |
RGD:6483315 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Gfap |
glial fibrillary acidic protein |
|
IEP |
|
RGD |
PMID:8833197 |
RGD:6480531 |
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
|
ISO |
human protein in a rat model |
RGD |
PMID:17014847 |
RGD:13504858 |
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:12002507 |
RGD:8548865 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:12002507 |
RGD:8548865 |
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Vim |
vimentin |
|
IEP |
|
RGD |
PMID:8833197 |
RGD:6480531 |
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28038895 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Tp63 |
tumor protein p63 |
|
ISO |
|
RGD |
PMID:12167247 |
RGD:11568649 |
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
|
G |
Ifng |
interferon gamma |
|
ISO |
mRNA,protein:increased expression:corneal |
RGD |
PMID:15832292 |
RGD:8157597 |
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
|
IEP |
mRNA:increased expression:superior cervical ganglion |
RGD |
PMID:16420416 |
RGD:2289006 |
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:15153618 |
RGD:4891994 |
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
|
|
|
G |
Adnp |
activity-dependent neuroprotector homeobox |
|
ISO |
|
RGD |
PMID:11123362 |
RGD:2312784 |
NCBI chr 3:156,886,921...156,921,500
Ensembl chr 3:156,891,381...156,917,312
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
protein:increased expression:microglial cell |
RGD |
PMID:7830934 |
RGD:10045949 |
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Postn |
periostin |
|
IEP |
|
RGD |
PMID:17878602 |
RGD:10041014 |
NCBI chr 2:138,527,714...138,559,098
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Serpinc1 |
serpin family C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8810955 |
|
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
|
|
|
G |
S100b |
S100 calcium binding protein B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30076900 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
|
G |
Il10 |
interleukin 10 |
treatment |
IDA |
|
RGD |
PMID:22553604 |
RGD:7364851 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:retina |
RGD |
PMID:9618720 |
RGD:7794723 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
IEP |
protein:increased expression:cornea, neutrophil, macrophage (rat) |
RGD |
PMID:24194635 |
RGD:8552904 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO IEP |
protein:increased expression:lens |
RGD |
PMID:15273655 PMID:15273655 |
RGD:8655664, RGD:8655664 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Mir183 |
microRNA 183 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27208084 |
|
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
|
|
G |
Mir96 |
microRNA 96 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27208084 |
|
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
treatment |
ISO |
|
RGD |
PMID:18658087 |
RGD:8552893 |
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
IEP |
mRNA:increased expression:facial VII nucleus |
RGD |
PMID:19427307 |
RGD:2325258 |
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Atf2 |
activating transcription factor 2 |
|
IEP |
|
RGD |
PMID:9813301 |
RGD:10047413 |
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:19922414 |
RGD:6892922 |
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
|
|
G |
Cd59b |
CD59b molecule |
|
IEP |
mRNA, protein:increased expression:facial VII nucleus |
RGD |
PMID:9846834 |
RGD:1600495 |
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Csf1 |
colony stimulating factor 1 |
|
IEP |
protein:increased expression:facial VII nerve, microglial cell |
RGD |
PMID:20831658 |
RGD:5131509 |
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Ctss |
cathepsin S |
|
ISO |
|
RGD |
PMID:17539023 |
RGD:5686912 |
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
|
IEP |
mRNA:increased expression:facial VII nucleus |
RGD |
PMID:9582449 |
RGD:6218984 |
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Hgf |
hepatocyte growth factor |
treatment |
IDA |
|
RGD |
PMID:21562589 |
RGD:8548634 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Mt3 |
metallothionein 3 |
treatment |
IDA |
|
RGD |
PMID:14625437 |
RGD:9685806 |
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Ndufa5 |
NADH:ubiquinone oxidoreductase subunit A5 |
|
IEP |
mRNA:increased expression:skeletal muscle |
RGD |
PMID:8875451 |
RGD:2302319 |
NCBI chr 4:52,997,327...53,005,685
Ensembl chr 4:52,995,546...53,005,598
|
|
G |
Ret |
ret proto-oncogene |
|
IEP |
mRNA:increased expression:facial VII nucleus |
RGD |
PMID:9582449 |
RGD:6218984 |
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
|
G |
Acvr1b |
activin A receptor type 1B |
|
IEP |
|
RGD |
PMID:9013782 |
RGD:151665480 |
NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:132,286,275...132,329,673
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
IEP |
mRNA:increased expression:hypoglossal nerve |
RGD |
PMID:11311987 |
RGD:5037239 |
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
|
RGD |
PMID:9698327 |
RGD:704401 |
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Csnk2b |
casein kinase 2 beta |
|
IEP |
|
RGD |
PMID:11068334 |
RGD:11565824 |
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
IEP |
|
RGD |
PMID:9183688 |
RGD:8655640 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
IEP |
|
RGD |
PMID:9183688 |
RGD:8655640 |
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
|
IEP |
mRNA:increased expression:hypoglossal XII nerve |
RGD |
PMID:10407179 |
RGD:6218979 |
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
IEP |
mRNA:increased expression:hypoglossal nerve |
RGD |
PMID:11311987 |
RGD:5037239 |
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Mcam |
melanoma cell adhesion molecule |
|
IEP |
|
RGD |
PMID:10076889 |
RGD:7364787 |
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G |
Mme |
membrane metallo-endopeptidase |
|
IEP |
|
RGD |
PMID:8201016 |
RGD:13801045 |
NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
IEP |
|
RGD |
PMID:7769990 |
RGD:7327191 |
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
|
IEP |
|
RGD |
PMID:7769990 |
RGD:7327191 |
NCBI chr 2:235,636,878...235,726,928
Ensembl chr 2:235,636,885...235,726,198
|
|
G |
Ret |
ret proto-oncogene |
|
IEP |
mRNA:increased expression:hypoglossal XII nerve |
RGD |
PMID:10407179 |
RGD:6218979 |
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
G |
Smad1 |
SMAD family member 1 |
|
IEP |
mRNA:increased expression:hypoglossal nucleus |
RGD |
PMID:17166487 |
RGD:1643227 |
NCBI chr19:28,513,130...28,573,665
Ensembl chr19:28,513,131...28,573,651
|
|
G |
Smad2 |
SMAD family member 2 |
|
IEP |
mRNA:increased expression:hypoglossal nucleus |
RGD |
PMID:17166487 |
RGD:1643227 |
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
|
IEP |
mRNA:increased expression:hypoglossal nucleus |
RGD |
PMID:17166487 |
RGD:1643227 |
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad4 |
SMAD family member 4 |
|
IEP |
mRNA:increased expression:hypoglossal nucleus |
RGD |
PMID:17166487 |
RGD:1643227 |
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smad7 |
SMAD family member 7 |
|
IEP |
mRNA:increased expression:hypoglossal nucleus |
RGD |
PMID:17166487 |
RGD:1643227 |
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smad9 |
SMAD family member 9 |
|
IEP |
mRNA:decreased expression:hypoglossal nucleus |
RGD |
PMID:17166487 |
RGD:1643227 |
NCBI chr 2:138,956,326...139,006,315
Ensembl chr 2:138,986,471...139,006,307
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
|
IEP |
mRNA, protein:increased expression:neuron |
RGD |
PMID:19833109 |
RGD:5133729 |
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
|
G |
Gp6 |
glycoprotein VI |
exacerbates |
ISO |
|
RGD |
PMID:21258336 |
RGD:401824683 |
NCBI chr 1:69,429,232...69,492,709
Ensembl chr 1:69,465,789...69,491,326
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
treatment |
IMP |
|
RGD |
PMID:34334113 |
RGD:155882538 |
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Zeb2 |
zinc finger E-box binding homeobox 2 |
treatment |
IMP IEP |
protein:increased expression:brain (rat) |
RGD |
PMID:34334113 PMID:34334113 |
RGD:155882538, RGD:155882538 |
NCBI chr 3:29,214,581...29,344,890
Ensembl chr 3:29,218,301...29,345,157
|
|
|
G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
IEP |
mRNA:decreased expression:bone |
RGD |
PMID:19607804 |
RGD:5147852 |
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
|
IEP |
|
RGD |
PMID:23992905 |
RGD:12911207 |
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
IEP |
mRNA:increased expression:motor neuron |
RGD |
PMID:21456016 |
RGD:5684341 |
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
|
G |
Adcy10 |
adenylate cyclase 10 |
|
IEP |
protein:decreased expression:retina |
RGD |
PMID:22649251 |
RGD:329347828 |
NCBI chr13:77,747,752...77,833,952
Ensembl chr13:77,768,468...77,833,951
|
|
G |
Adnp |
activity-dependent neuroprotector homeobox |
|
IDA |
|
RGD |
PMID:18414890 |
RGD:2312783 |
NCBI chr 3:156,886,921...156,921,500
Ensembl chr 3:156,891,381...156,917,312
|
|
G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
treatment |
IEP |
|
RGD |
PMID:23613963 |
RGD:14390159 |
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
|
|
G |
Aqp4 |
aquaporin 4 |
|
IEP |
|
RGD |
PMID:20216911 |
RGD:2326035 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Aqp9 |
aquaporin 9 |
|
IEP |
|
RGD |
PMID:20216911 |
RGD:2326035 |
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Arg2 |
arginase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30618589 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Atf2 |
activating transcription factor 2 |
|
IEP |
|
RGD |
PMID:10366744 |
RGD:10047417 |
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
IEP |
mRNA:increased expression:optic nerve, retina |
RGD |
PMID:24357921 |
RGD:10054098 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
IEP |
mRNA:decreased expression:optic nerve, retina |
RGD |
PMID:24357921 |
RGD:10054098 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
treatment |
ISO IEP |
|
RGD |
PMID:15140649 PMID:11050383 PMID:9520478 |
RGD:8655584, RGD:8655586, RGD:8655637 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
C3 |
complement C3 |
|
IEP |
mRNA:increased expression:optic nerve |
RGD |
PMID:14577867 |
RGD:5129542 |
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
|
IEP |
mRNA:increased expression:retina |
RGD |
PMID:16723461 |
RGD:2293567 |
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cfl1 |
cofilin 1 |
treatment |
IDA |
|
RGD |
PMID:27443501 |
RGD:11568693 |
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Clu |
clusterin |
|
IEP |
|
RGD |
PMID:14577867 |
RGD:5129542 |
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
IEP |
mRNA:increased expression:retina (rat) |
RGD |
PMID:20187850 |
RGD:151665810 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:20144610 |
RGD:11039471 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctsb |
cathepsin B |
|
IEP |
protein:increased expression:retina (rat) |
RGD |
PMID:18775855 |
RGD:2315508 |
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Edn1 |
endothelin 1 |
|
IEP |
protein:increased expression:retina |
RGD |
PMID:18600494 |
RGD:4892579 |
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
|
IEP |
mRNA:increased expression:retina |
RGD |
PMID:18600494 |
RGD:4892579 |
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
|
IEP |
mRNA:increased expression:retina |
RGD |
PMID:18600494 |
RGD:4892579 |
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Ep300 |
E1A binding protein p300 |
|
IEP ISO |
protein:decreased expression:retinal ganglion cell layer (rat) human gene in rat model |
RGD |
PMID:21705428 PMID:21705428 |
RGD:7349392, RGD:7349392 |
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:14664816 |
RGD:8554854 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
|
IEP |
mRNA:increased expression:retina |
RGD |
PMID:33664770 |
RGD:329951020 |
NCBI chr19:15,284,898...15,692,142
Ensembl chr19:15,349,696...15,692,083
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
IEP |
|
RGD |
PMID:15144875 |
RGD:6218970 |
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
|
IEP |
|
RGD |
PMID:15144875 |
RGD:6218970 |
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gfra2 |
GDNF family receptor alpha 2 |
|
IEP |
|
RGD |
PMID:15144875 |
RGD:6218970 |
NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714
|
|
G |
Hgf |
hepatocyte growth factor |
treatment |
ISO |
|
RGD |
PMID:21443522 |
RGD:8548549 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IMP IEP |
protein: altered activity: eye protein:increased expression:retina: |
RGD |
PMID:19484445 PMID:23648097 |
RGD:5686431, RGD:10046025 |
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
IEP |
|
RGD |
PMID:10366744 |
RGD:10047417 |
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
|
IEP |
|
RGD |
PMID:20216911 |
RGD:2326035 |
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
|
ISO |
mRNA:increased expression:retina |
RGD |
PMID:12076086 |
RGD:8662362 |
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Myrf |
myelin regulatory factor |
|
IEP |
mRNA:decreased expression: oligodendrocyte |
RGD |
PMID:29915135 |
RGD:213230153 |
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
treatment |
IMP |
|
RGD |
PMID:28032230 |
RGD:13781885 |
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
|
RGD |
PMID:18757519 |
RGD:2326023 |
NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
|
|
G |
Nefm |
neurofilament medium chain |
|
IEP |
|
RGD |
PMID:8501527 |
RGD:9743936 |
NCBI chr15:42,360,449...42,365,753
Ensembl chr15:42,360,454...42,365,755
|
|
G |
Neo1 |
neogenin 1 |
|
IEP |
protein:increased expression:retina |
RGD |
PMID:21887516 |
RGD:9850142 |
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
|
|
G |
Ngfr |
nerve growth factor receptor |
|
IDA |
|
RGD |
PMID:20943663 |
RGD:5508695 |
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
IDA |
|
RGD |
PMID:20943663 |
RGD:5508695 |
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
IDA |
|
RGD |
PMID:20357199 |
RGD:5684908 |
NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
IEP |
mRNA:increased expression:retina: |
RGD |
PMID:12836167 |
RGD:1299297 |
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pax6 |
paired box 6 |
|
IEP |
protein:increased expression:retina (rat) |
RGD |
PMID:23297010 |
RGD:8552379 |
NCBI chr 3:92,128,772...92,157,022
Ensembl chr 3:92,135,637...92,157,014
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
protein:decreased expression:nerve fiber: |
RGD |
PMID:9893812 |
RGD:10449496 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
|
IEP |
protein:increased expression:optic nerve (rat) |
RGD |
PMID:22336118 |
RGD:6767293 |
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IEP |
mRNA:increased expression:optic nerve (rat) |
RGD |
PMID:20798533 |
RGD:6483802 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Ptpn5 |
protein tyrosine phosphatase, non-receptor type 5 |
|
IEP |
protein:increased expression:retina (rat) |
RGD |
PMID:15555919 |
RGD:9835027 |
NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:97,620,642...97,679,882
|
|
G |
Rhoa |
ras homolog family member A |
|
IEP |
protein:increased expression, altered localization:retina |
RGD |
PMID:17534117 |
RGD:1642826 |
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Snw1 |
SNW domain containing 1 |
|
IEP |
protein:increased expression:retina (rat) |
RGD |
PMID:25074585 |
RGD:11035254 |
NCBI chr 6:107,095,450...107,119,536
Ensembl chr 6:107,095,457...107,119,536
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
protein:increased expression:optic nerve |
RGD |
PMID:23103505 |
RGD:7794777 |
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP ISO |
|
RGD |
PMID:18552980 PMID:14697498 |
RGD:7794683, RGD:8661743 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
|
IEP |
protein:increased expression: retina |
RGD |
PMID:18552980 |
RGD:7794683 |
NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
|
|
G |
Ybx3 |
Y box binding protein 3 |
|
IEP |
mRNA:increased expression:retinal ganglion cell |
RGD |
PMID:11750989 |
RGD:2311250 |
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
|
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
mRNA:increased expression:retina |
RGD |
PMID:9268592 |
RGD:8655567 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Neo1 |
neogenin 1 |
|
IEP |
protein:increased expression:retina |
RGD |
PMID:21887516 |
RGD:9850142 |
NCBI chr 8:59,273,860...59,426,486
Ensembl chr 8:59,275,569...59,430,348
|
|
G |
Rgma |
repulsive guidance molecule BMP co-receptor a |
|
IEP |
protein:increased expression:retina |
RGD |
PMID:21887516 |
RGD:9850142 |
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
|
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
|
IEP |
protein:increased expression,increased activity:cerebral cortex: |
RGD |
PMID:16672190 |
RGD:9685448 |
NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
IEP |
mRNA,protein:increased expression:astrocyte,macrophage,neutrophil: |
RGD |
PMID:11168551 |
RGD:10402049 |
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Gfap |
glial fibrillary acidic protein |
|
ISO |
|
RGD |
PMID:10225952 |
RGD:6480471 |
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
IEP |
protein:increased expression:neuron: |
RGD |
PMID:7526956 |
RGD:10449485 |
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
|
|
G |
Vim |
vimentin |
|
ISO |
|
RGD |
PMID:10225952 |
RGD:6480471 |
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25014009 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Ank3 |
ankyrin 3 |
|
IEP |
mRNA:decreased expression:neuron |
RGD |
PMID:10915577 |
RGD:6767305 |
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
IEP |
protein:increased expression:sciatic nerve (rat) |
RGD |
PMID:2120218 |
RGD:2311210 |
NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
|
|
G |
Apoe |
apolipoprotein E |
|
ISO IEP |
mouse model treated with human peptide protein:increased expression:sciatic nerve (rat) |
RGD |
PMID:20406857 PMID:2419900 |
RGD:6906874, RGD:6906875 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
IEP ISO |
mRNA,protein:increased expression:fourth lumbar dorsal root ganglion: mRNA,protein:increased expression:spinal dorsal horn: |
RGD |
PMID:11425916 PMID:23466809 |
RGD:8657088, RGD:8657102 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Capn2 |
calpain 2 |
|
IEP |
|
RGD |
PMID:25150005 |
RGD:13792585 |
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Cbl |
Cbl proto-oncogene |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:30021515 |
RGD:126925240 |
NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
|
|
G |
Cblb |
Cbl proto-oncogene B |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:30021515 |
RGD:126925240 |
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
L5 spinal nerve;proein:increased expression:rostral ventrolateral medulla (rat) |
RGD |
PMID:22466130 |
RGD:8549494 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Chl1 |
cell adhesion molecule L1-like |
|
IEP IMP |
mRNA, protein:increased expression:dorsal root ganglia (rat) |
RGD |
PMID:21452236 PMID:21452236 |
RGD:6483040, RGD:6483040 |
NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
|
IEP |
protein:increased expression:spinal nerve |
RGD |
PMID:15652389 |
RGD:150530460 |
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Dag1 |
dystroglycan 1 |
|
IEP |
|
RGD |
PMID:16254495 |
RGD:11541065 |
NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325
|
|
G |
Ephb2 |
Eph receptor B2 |
|
IEP |
mRNA,protein:increased expression:dorsal root ganglion |
RGD |
PMID:32149862 |
RGD:127285658 |
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Gh1 |
growth hormone 1 |
treatment |
ISO |
|
RGD |
PMID:21945950 |
RGD:10003150 |
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Hhip |
Hedgehog-interacting protein |
|
IEP |
|
RGD |
PMID:19515211 |
RGD:11552601 |
NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
IEP |
mRNA:increased expression |
RGD |
PMID:21940431 |
RGD:5685664 |
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
|
IEP |
protein:decreased expression: : |
RGD |
PMID:21693130 |
RGD:6480665 |
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Il18 |
interleukin 18 |
|
IEP |
|
RGD |
PMID:23000553 |
RGD:8655963 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
tibial and peroneal nerves |
RGD |
PMID:23121415 |
RGD:7204126 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
|
IEP |
|
RGD |
PMID:21492407 |
RGD:10402827 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
|
IEP |
|
RGD |
PMID:21492407 |
RGD:10402827 |
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Irf5 |
interferon regulatory factor 5 |
|
IEP |
protein:increased expression:spinal dorsal horn |
RGD |
PMID:29927790 |
RGD:40924654 |
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
|
|
G |
Kcnb1 |
potassium voltage-gated channel subfamily B member 1 |
|
IEP |
protein:decreased expression:tibial nerve, motor neuron, neuronal cell body (rat) |
RGD |
PMID:24355600 |
RGD:126908004 |
NCBI chr 3:155,820,255...155,913,383
Ensembl chr 3:155,822,963...155,916,194
|
|
G |
L1cam |
L1 cell adhesion molecule |
|
ISO IDA |
|
RGD |
PMID:21376041 PMID:17640175 |
RGD:6483044, RGD:6483092 |
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
|
|
G |
Mir96 |
microRNA 96 |
|
IEP |
RNA:altered expression:dorsal root ganglion: |
RGD |
PMID:19699278 |
RGD:11553934 |
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
IEP |
|
RGD |
PMID:17027671 |
RGD:2325934 |
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
|
IEP |
|
RGD |
PMID:17027671 |
RGD:2325934 |
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Ngf |
nerve growth factor |
|
IEP |
mRNA,protein:increased expression:sciatic nerve: |
RGD |
PMID:11425916 |
RGD:8657088 |
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Ngfr |
nerve growth factor receptor |
treatment |
IDA IEP |
|
RGD |
PMID:22669154 PMID:22302815 |
RGD:10413899, RGD:10413905 |
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nog |
noggin |
treatment |
ISO |
|
RGD |
PMID:17258709 |
RGD:10428775 |
NCBI chr10:74,128,712...74,130,339
Ensembl chr10:74,128,712...74,130,339
|
|
G |
Nts |
neurotensin |
|
IEP |
mRNA,protein:increased expression:neuron: |
RGD |
PMID:8866516 |
RGD:9743915 |
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
G |
P2rx4 |
purinergic receptor P2X 4 |
sexual_dimorphism |
IEP |
in male rat; protein:increased expression:microglia |
RGD |
PMID:29927790 |
RGD:40924654 |
NCBI chr12:33,844,609...33,862,265
Ensembl chr12:33,844,396...33,862,253
|
|
G |
Plau |
plasminogen activator, urokinase |
|
IEP |
Cavernous Nerve Injury; mRNA:increased expression:pelvic ganglion (rat) |
RGD |
PMID:22300381 |
RGD:7241556 |
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Procr |
protein C receptor |
|
IEP |
|
RGD |
PMID:27771530 |
RGD:13515125 |
NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
disease_progression |
IEP |
|
RGD |
PMID:14576556 |
RGD:5688234 |
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IEP ISO |
protein:increased expression: |
RGD |
PMID:14871450 PMID:14871450 |
RGD:5688227, RGD:5688227 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Reg3b |
regenerating family member 3 beta |
|
IEP |
mRNA:increased expression:hypoglossal nerve (rat) |
RGD |
PMID:15896308 |
RGD:9831386 |
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
IEP |
mRNA:increased expression:pelvic ganglion (rat) |
RGD |
PMID:22300381 |
RGD:7241556 |
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Shh |
sonic hedgehog signaling molecule |
|
IEP |
|
RGD |
PMID:22994531 |
RGD:12879407 |
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
|
|
G |
Tnf |
tumor necrosis factor |
|
IEP |
protein:increased expression:dorsal root ganglion: protein:increased expression:nucleus accumbens |
RGD |
PMID:19543754 PMID:24845379 |
RGD:7394752, RGD:10450588 |
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
|
IEP |
protein:increased expression:dorsal root ganglion: |
RGD |
PMID:18514429 |
RGD:10043379 |
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
|
G |
Trh |
thyrotropin releasing hormone |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:8690305 |
|
NCBI chr 4:124,742,111...124,777,094
Ensembl chr 4:124,742,111...124,744,637
|
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
treatment |
ISO |
|
RGD |
PMID:16332232 |
RGD:8699514 |
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Igf1 |
insulin-like growth factor 1 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:12002507 |
RGD:8548865 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
|
G |
Adamts13 |
ADAM metallopeptidase with thrombospondin type 1 motif, 13 |
|
IEP |
mRNA, protein:increased expression, increased activity:spinal cord (rat) |
RGD |
PMID:22425718 |
RGD:10449098 |
NCBI chr 3:10,299,264...10,338,464
Ensembl chr 3:10,300,028...10,346,687
|
|
G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
|
IEP |
mRNA, protein:increased expression:dorsal root ganglion (rat) |
RGD |
PMID:23613963 |
RGD:14390159 |
NCBI chr 8:108,741,899...108,743,425
Ensembl chr 8:108,693,060...108,744,555
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP ISO |
mRNA, protein:increased expression:liver, serum (rat) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15135227 PMID:15855648 |
RGD:11526154 |
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cd163 |
CD163 molecule |
disease_progression |
IEP |
protein:increased expression:gray matter of spinal cord, white matter of spinal cord (rat) |
RGD |
PMID:23775900 |
RGD:149735576 |
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
|
|
G |
Chst14 |
carbohydrate sulfotransferase 14 |
exacerbates |
ISO |
|
RGD |
PMID:26586562 |
RGD:155663489 |
NCBI chr 3:105,916,481...105,918,538
Ensembl chr 3:105,916,466...105,918,548
|
|
G |
Egr1 |
early growth response 1 |
|
IEP |
protein:increased expression:spinal cord dorsal horn (rat) |
RGD |
PMID:20675054 |
RGD:5131876 |
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Elane |
elastase, neutrophil expressed |
treatment |
IMP |
|
RGD |
PMID:9675307 |
RGD:10450552 |
NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
|
|
G |
Epo |
erythropoietin |
|
IEP |
protein:increased expression:neuron, endothelium, glia: |
RGD |
PMID:15792521 |
RGD:11041719 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Epor |
erythropoietin receptor |
|
IEP |
protein:increased expression:neuron, endothelium, glia: |
RGD |
PMID:15792521 |
RGD:11041719 |
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
|
|
G |
Fas |
Fas cell surface death receptor |
treatment |
ISO |
human protein in a rat model protein:increased expression:spinal cord: |
RGD |
PMID:16689665 PMID:21490053 PMID:16202410 |
RGD:1582444, RGD:12904017, RGD:8663485 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
treatment |
ISO |
protein:increased expression:spinal cord: |
RGD |
PMID:21490053 PMID:21490053 |
RGD:12904017, RGD:12904017 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:17244329 |
RGD:8655633 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
IEP |
protein:increased expression:spinal cord (rat) |
RGD |
PMID:28981091 |
RGD:155782905 |
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fis1 |
fission, mitochondrial 1 |
treatment |
IEP |
|
RGD |
PMID:25595990 |
RGD:12437079 |
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
|
IEP |
protein:decreased expression:spinal cord, thoracic vertebrae (rat) |
RGD |
PMID:20399821 |
RGD:2326108 |
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
|
ISO |
protein:increased expression:spinal cord (mouse) |
RGD |
PMID:21787762 |
RGD:6218959 |
NCBI chr10:37,408,025...37,449,080
Ensembl chr10:37,408,025...37,449,001
|
|
G |
Il6 |
interleukin 6 |
|
IEP |
protein:increased expression:cerebrospinal fluid, serum |
RGD |
PMID:30327453 |
RGD:14975119 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itgam |
integrin subunit alpha M |
treatment |
IEP |
|
RGD |
PMID:19457130 |
RGD:329902059 |
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
L1cam |
L1 cell adhesion molecule |
|
ISO |
|
RGD |
PMID:21671795 |
RGD:6483029 |
NCBI chr X:151,597,270...151,623,776
Ensembl chr X:151,597,277...151,623,857
|
|
G |
Mir17 |
microRNA 17 |
treatment |
IMP |
|
RGD |
PMID:31115018 |
RGD:329403058 |
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mt2A |
metallothionein 2A |
|
ISO |
mRNA:increased expression:spinal cord (mouse) |
RGD |
PMID:15592854 |
RGD:6483848 |
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
|
RGD |
PMID:29323048 |
RGD:13504709 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12227717 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15135227 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
IEP |
protein:increased expression:spinal cord (rat) |
RGD |
PMID:21224756 |
RGD:5130917 |
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
IEP ISO |
protein:increased expression:spinal cord (rat) human protein in rat model |
RGD |
PMID:21224756 PMID:21224756 |
RGD:5130917, RGD:5130917 |
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
treatment |
ISO IEP IMP |
mRNA:increased expression:spinal cord |
RGD |
PMID:20410530 PMID:25763638 PMID:20410530 PMID:20410530 |
RGD:12790978, RGD:12791993, RGD:12790978, RGD:12790978 |
NCBI chr 1:96,598,568...96,679,563
Ensembl chr 1:96,598,647...96,679,510
|
|
G |
Acan |
aggrecan |
|
IEP |
protein:altered expression:spinal cord (rat) |
RGD |
PMID:14769391 |
RGD:2315837 |
NCBI chr 1:132,981,582...133,044,416
Ensembl chr 1:132,981,582...133,043,627
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
|
IDA |
|
RGD |
PMID:20456005 |
RGD:10755338 |
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
IEP IDA |
protein:altered expression:spinal cord,dorsal root ganglion, urinary bladder |
RGD |
PMID:15698618 PMID:15913892 |
RGD:2325309, RGD:2325306 |
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16213239 |
RGD:5686719 |
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Adora1 |
adenosine A1 receptor |
|
IMP IDA IEP |
protein:decreased expression:spinal cord |
RGD |
PMID:18289533 PMID:20065990 PMID:17853654 |
RGD:5129096, RGD:5129094, RGD:4890369 |
NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801
|
|
G |
Adora2a |
adenosine A2a receptor |
|
IEP |
|
RGD |
PMID:17559837 |
RGD:4890378 |
NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
|
IEP |
mRNA:increased expression:aorta |
RGD |
PMID:16524515 |
RGD:5688371 |
NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IEP |
protein:increased expression:spinal cord (rat) |
RGD |
PMID:20195207 |
RGD:2325645 |
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
|
IEP |
protein:altered expression:spinal cord dorsal horn (rat) |
RGD |
PMID:17158026 |
RGD:2313037 |
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
IEP |
|
RGD |
PMID:20678995 |
RGD:10040962 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt1s1 |
AKT1 substrate 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17457363 |
|
NCBI chr 1:95,333,186...95,339,678
Ensembl chr 1:95,332,898...95,339,677
|
|
G |
Ambra1 |
autophagy and beclin 1 regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29793971 |
|
NCBI chr 3:77,700,936...77,890,221
Ensembl chr 3:77,700,936...77,890,221
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
|
IEP |
mRNA:increased expression:spinal cord, dorsal root ganglion, neuron |
RGD |
PMID:17610582 |
RGD:5133279 |
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
|
IEP |
|
RGD |
PMID:25034417 |
RGD:10401137 |
NCBI chr 5:60,743,077...60,765,726
Ensembl chr 5:60,743,443...60,765,717
|
|
G |
Anxa1 |
annexin A1 |
treatment |
ISO IEP |
mRNA,protein:increased expression:neuron,glial cell |
RGD |
PMID:17917587 PMID:15248295 |
RGD:2306891, RGD:10053688 |
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
|
IEP |
mRNA,protein:increased expression:neuron,glial cell |
RGD |
PMID:15248295 |
RGD:10053688 |
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Anxa5 |
annexin A5 |
|
IEP |
mRNA,protein:increased expression:neuron,glial cell |
RGD |
PMID:15248295 |
RGD:10053688 |
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
|
IEP |
|
RGD |
PMID:21748659 |
RGD:10053608 |
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:18637713 |
RGD:2315670 |
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
|
|
G |
Apoe |
apolipoprotein E |
|
ISO IEP |
DNA:polymorphism:exon: |
RGD |
PMID:18581664 PMID:30036659 |
RGD:7771551, RGD:13703128 |
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Aqp1 |
aquaporin 1 |
|
IEP ISO |
protein:increased expression:spinal cord, neuron, astrocyte CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21092735 PMID:18248364 PMID:21092735 |
RGD:2307072, RGD:5148013 |
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Aqp4 |
aquaporin 4 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21092735 PMID:21092735 PMID:21280976 PMID:20517941 |
RGD:5148013, RGD:5148035, RGD:5148027 |
NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856
|
|
G |
Atf4 |
activating transcription factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29793971 |
|
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
|
|
G |
Atg5 |
autophagy related 5 |
|
IEP ISO |
protein:increased expression:axon CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29793971 PMID:25040536 |
RGD:11553820 |
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Atg7 |
autophagy related 7 |
|
IEP |
protein:increased expression:axon |
RGD |
PMID:25040536 |
RGD:11553820 |
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:21748659 |
RGD:10053608 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp2a1 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 |
|
IEP |
protein:decreased expression:tail, skeletal muscle |
RGD |
PMID:21930674 |
RGD:13782071 |
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
|
IEP |
protein:decreased expression:tail, skeletal muscle |
RGD |
PMID:21930674 |
RGD:13782071 |
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
|
IEP |
mRNA,protein:decreased expression:spinal cord: |
RGD |
PMID:28035406 |
RGD:14390163 |
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:27256506 |
RGD:13792677 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcan |
brevican |
treatment |
IEP |
|
RGD |
PMID:15016081 |
RGD:9589823 |
NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:27256506 |
RGD:13792677 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
treatment |
ISO IDA IEP |
|
RGD |
PMID:16022868 PMID:24551172 PMID:19203225 |
RGD:4891112, RGD:10059354, RGD:4891066 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO IEP |
protein:increased expression:spinal cord CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29793971 PMID:21806471 PMID:23852559 PMID:24559459 |
RGD:6483100, RGD:11561922, RGD:11561918 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
|
IDA |
|
RGD |
PMID:23770801 |
RGD:9068404 |
NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
treatment |
IDA ISO |
|
RGD |
PMID:23770801 PMID:18803859 |
RGD:9068404, RGD:9068437 |
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:23637053 |
RGD:11564330 |
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:23637053 |
RGD:11564330 |
NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
IEP |
mRNA,protein:increased expression:spinal cord: |
RGD |
PMID:21748659 |
RGD:10053608 |
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
C1qb |
complement C1q B chain |
|
IEP |
mRNA:increased expression |
RGD |
PMID:16345062 |
RGD:1599510 |
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
|
|
G |
Capn1 |
calpain 1 |
treatment |
IMP |
|
RGD |
PMID:23102374 |
RGD:13792496 |
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
|
IEP |
protein:decreased expression:spinal cord |
RGD |
PMID:20141154 |
RGD:9685028 |
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Casp1 |
caspase 1 |
|
IDA |
protein:increased expression, increased activation:spinal cord |
RGD |
PMID:18367607 |
RGD:2315889 |
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp12 |
caspase 12 |
treatment |
IEP IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:19215662 PMID:26884858 |
RGD:2311450, RGD:11560925 |
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
treatment |
IMP IEP IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:14588118 PMID:18378144 PMID:27256506 PMID:27339639 PMID:21748659 |
RGD:2293322, RGD:13792677, RGD:13782345, RGD:10053608 |
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
treatment |
IEP IDA |
|
RGD |
PMID:21748659 PMID:27339639 |
RGD:10053608, RGD:13782345 |
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cav1 |
caveolin 1 |
|
IEP |
protein:increased phosphorylation:spinal cord |
RGD |
PMID:17275798 |
RGD:2289124 |
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:9698165 |
RGD:5135274 |
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:spinal cord segment (mouse) |
RGD |
PMID:20478301 |
RGD:4889905 |
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnd3 |
cyclin D3 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:18008145 |
RGD:2316019 |
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Ccne1 |
cyclin E1 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:16759516 |
RGD:2289281 |
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccnh |
cyclin H |
|
IEP |
mRNA, protein:increased expression:spinal cord |
RGD |
PMID:21710280 |
RGD:9590263 |
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
IEP |
|
RGD |
PMID:21332278 |
RGD:5688138 |
NCBI chr 8:123,556,286...123,561,841
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:18338959 |
RGD:4144888 |
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Cd274 |
CD274 molecule |
|
IEP |
mRNA:increased expression:microglial cell |
RGD |
PMID:29665726 |
RGD:40886268 |
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cdc42 |
cell division cycle 42 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:15736231 |
RGD:5688276 |
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
|
IEP |
protein:increased expression:spinal cord dura mater (rat) |
RGD |
PMID:19672039 |
RGD:2316488 |
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk19 |
cyclin-dependent kinase 19 |
|
IEP |
mRNA, protein:increased expression:spinal cord |
RGD |
PMID:18008145 |
RGD:2316019 |
NCBI chr20:43,770,409...43,910,629
Ensembl chr20:43,770,409...43,910,628
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IDA |
protein:decreased expression, altered localization:spinal cord, neuron, microglial cell |
RGD |
PMID:18319192 |
RGD:2293615 |
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Chl1 |
cell adhesion molecule L1-like |
|
IEP |
protein:increased expression:spinal cord (rat) |
RGD |
PMID:21337374 |
RGD:6483045 |
NCBI chr 4:136,291,504...136,505,830
Ensembl chr 4:136,291,463...136,503,265
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
IEP |
|
RGD |
PMID:18930143 |
RGD:2316199 |
NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
IEP |
|
RGD |
PMID:18930143 |
RGD:2316199 |
NCBI chr 5:148,125,222...148,151,548
Ensembl chr 5:148,125,604...148,151,548
|
|
G |
Cr2 |
complement C3d receptor 2 |
|
IEP |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:26502875 |
RGD:11343913 |
NCBI chr13:106,678,579...106,716,595
Ensembl chr13:106,685,413...106,716,235
|
|
G |
Crh |
corticotropin releasing hormone |
|
IEP |
protein:altered expression:spinal cord (rat) |
RGD |
PMID:20458328 |
RGD:5490964 |
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Crp |
C-reactive protein |
|
IDA |
|
RGD |
PMID:22404382 |
RGD:6903321 |
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
|
|
G |
Csf2 |
colony stimulating factor 2 |
treatment |
ISO |
|
RGD |
PMID:15658127 |
RGD:10449531 |
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
|
RGD |
PMID:21953623 |
RGD:10450511 |
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cspg4 |
chondroitin sulfate proteoglycan 4 |
|
ISO IDA |
|
RGD |
PMID:22243800 PMID:19604403 PMID:22042562 |
RGD:5686844, RGD:5686859, RGD:5686848 |
NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
|
|
G |
Ctss |
cathepsin S |
|
IEP |
|
RGD |
PMID:16344894 |
RGD:2303423 |
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:9698165 |
RGD:5135274 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
IEP |
|
RGD |
PMID:19170890 |
RGD:2311365 |
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:16345062 |
RGD:1599510 |
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
|
|
G |
Cybb |
cytochrome b-245 beta chain |
|
ISO |
mRNA,protein:increased expression:microglia: |
RGD |
PMID:20679217 |
RGD:11040629 |
NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Dab2 |
DAB adaptor protein 2 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:17317100 |
RGD:7243246 |
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
IEP |
|
RGD |
PMID:16998900 |
RGD:2314373 |
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29793971 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
treatment |
IEP |
protein:decreased expression:spinal cord |
RGD |
PMID:18630599 PMID:19383246 |
RGD:7771572, RGD:7771580 |
NCBI chr10:16,680,478...16,683,275
|
|
G |
Efnb2 |
ephrin B2 |
|
IEP |
mRNA,protein:increased expression:fibroblast, astrocyte protein:increased phosporylation:spinal cord |
RGD |
PMID:33794069 PMID:12944508 |
RGD:127285659, RGD:127285804 |
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egfr |
epidermal growth factor receptor |
|
IMP IEP |
protein:increased phosphorylation:spinal cord, astrocyte (rat) |
RGD |
PMID:20869112 PMID:21402118 |
RGD:5131525, RGD:5131454 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
IEP |
mRNA, protein:increased expression:gastrocnemius |
RGD |
PMID:23238062 |
RGD:10395360 |
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Endog |
endonuclease G |
|
IEP |
|
RGD |
PMID:16689664 |
RGD:8655990 |
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Eno2 |
enolase 2 |
|
IEP |
protein:increased expression:serum, cerebrospinal fluid |
RGD |
PMID:18343116 |
RGD:2293743 |
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Ensa |
endosulfine alpha |
|
IEP |
mRNA:decreased expression:spinal cord |
RGD |
PMID:16344894 |
RGD:2303423 |
NCBI chr 2:183,185,552...183,192,888
Ensembl chr 2:183,185,552...183,194,847
|
|
G |
Epha3 |
Eph receptor A3 |
|
IEP |
|
RGD |
PMID:16083359 |
RGD:2301766 |
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
|
|
G |
Epha4 |
Eph receptor A4 |
|
IMP IEP ISO |
|
RGD |
PMID:17970742 PMID:17418490 PMID:21931787 |
RGD:5688750, RGD:5688782, RGD:5688764 |
NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
|
|
G |
Epha7 |
Eph receptor A7 |
|
IMP |
mRNA:increased expression:spinal cord |
RGD |
PMID:16983667 |
RGD:2301957 |
NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112
|
|
G |
Ephb2 |
Eph receptor B2 |
ameliorates |
IMP IEP |
|
RGD |
PMID:33794069 PMID:12944508 |
RGD:127285659, RGD:127285804 |
NCBI chr 5:148,889,574...149,077,027
Ensembl chr 5:148,897,246...149,077,059
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:22196867 |
RGD:10401074 |
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
|
IEP |
mRNA, protein:increased expression:spinal cord |
RGD |
PMID:11797086 |
RGD:2289967 |
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IEP |
|
RGD |
PMID:25105782 |
RGD:10045844 |
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IEP |
|
RGD |
PMID:25105782 |
RGD:10045844 |
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F2 |
coagulation factor II, thrombin |
|
IEP |
|
RGD |
PMID:16344894 |
RGD:2303423 |
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:23574812 |
RGD:11344882 |
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP IDA |
protein:increased expression:cervical spinal cord |
RGD |
PMID:17518537 PMID:29738767 PMID:17703359 |
RGD:2290177, RGD:13792580, RGD:2290176 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
|
ISO IDA |
Human FGF1 used in rat model of spinal cord injury |
RGD |
PMID:21663406 PMID:18482974 PMID:20488178 PMID:8662542 |
RGD:5509875, RGD:2317692, RGD:5509877, RGD:5509876 |
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
treatment |
IEP |
|
RGD |
PMID:24968269 |
RGD:40924652 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fis1 |
fission, mitochondrial 1 |
treatment |
IEP |
|
RGD |
PMID:26079325 |
RGD:12437066 |
NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377
|
|
G |
Fkbp1b |
FKBP prolyl isomerase 1B |
|
IDA |
|
RGD |
PMID:27998200 |
RGD:329853757 |
NCBI chr 6:27,832,128...27,850,600
Ensembl chr 6:27,838,802...27,848,653
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
|
IEP |
mRNA:increased expression:spinal cord, astrocyte, macrophage |
RGD |
PMID:17409380 |
RGD:5684414 |
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fn1 |
fibronectin 1 |
|
ISO |
|
RGD |
PMID:20347014 |
RGD:7205459 |
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Foxo3 |
forkhead box O3 |
|
IEP |
protein:decreased expression:spinal cord,neuron, astrocyte: |
RGD |
PMID:22930444 |
RGD:10402202 |
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp3 |
forkhead box P3 |
treatment |
IEP |
|
RGD |
PMID:30287503 |
RGD:38549580 |
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Gap43 |
growth associated protein 43 |
treatment |
IEP |
|
RGD |
PMID:24968269 |
RGD:40924652 |
NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
treatment |
IDA |
|
RGD |
PMID:27256506 |
RGD:13792677 |
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
|
RGD |
PMID:22342994 |
RGD:5688774 |
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfap |
glial fibrillary acidic protein |
treatment |
ISO IEP |
protein:increased expression:spinal cord |
RGD |
PMID:10225952 PMID:24968269 PMID:21250919 |
RGD:6480471, RGD:40924652, RGD:6480511 |
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
|
RGD |
PMID:25261791 |
RGD:12907564 |
NCBI chr 2:110,268,489...110,271,865
Ensembl chr 2:110,268,489...110,271,865
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
treatment |
IMP IEP |
|
RGD |
PMID:23403365 PMID:24183749 |
RGD:8662431, RGD:8662460 |
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gjc2 |
gap junction protein, gamma 2 |
treatment |
IEP |
|
RGD |
PMID:26415641 |
RGD:13208513 |
NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
|
IEP |
protein:increased expression:spinal cord (rat) |
RGD |
PMID:27150525 |
RGD:13506243 |
NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:22975889 |
RGD:8552988 |
NCBI chr12:15,217,217...15,222,679
Ensembl chr12:15,217,442...15,221,889
|
|
G |
Grk6 |
G protein-coupled receptor kinase 6 |
|
IEP |
protein:increased expression:spinal cord, neuron, microglial cell (rat) |
RGD |
PMID:23359120 |
RGD:13792782 |
NCBI chr17:9,177,018...9,192,813
Ensembl chr17:9,177,019...9,192,644
|
|
G |
Grn |
granulin precursor |
|
ISO |
mRNA, protein:increased expression:spinal cord: |
RGD |
PMID:19946692 |
RGD:5509603 |
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
IEP |
mRNA:increased expression:lumbar segment of spinal cord (rat) |
RGD |
PMID:22160604 |
RGD:5687769 |
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Hgf |
hepatocyte growth factor |
treatment |
ISO IEP IDA |
mRNA,protein:increased expression:spinal cord: |
RGD |
PMID:22140459 PMID:17549731 PMID:17549731 |
RGD:8548666, RGD:2317487, RGD:2317487 |
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
IEP ISO |
protein:increased expression:spinal cord CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21092735 PMID:21092735 |
RGD:5148013 |
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:20195207 |
RGD:2325645 |
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
IEP |
|
RGD |
PMID:23943397 |
RGD:10766443 |
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hrh3 |
histamine receptor H3 |
|
IDA |
|
RGD |
PMID:16671478 |
RGD:1626425 |
NCBI chr 3:167,191,551...167,196,642
Ensembl chr 3:167,191,558...167,196,642
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
|
IEP |
protein:decreased expression:spinal cord (rat) |
RGD |
PMID:24499940 |
RGD:10445836 |
NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
mRNA: increased expression |
RGD |
PMID:21933012 |
RGD:5685666 |
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
treatment |
IEP |
mRNA,protein:increased expression:spinal cord: |
RGD |
PMID:12098653 PMID:30287503 |
RGD:10402749, RGD:38549580 |
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IMP |
|
RGD |
PMID:8627308 |
RGD:11522712 |
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:11746449 |
RGD:9686138 |
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:11746449 |
RGD:9686138 |
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:11746449 |
RGD:9686138 |
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Il10 |
interleukin 10 |
treatment |
IEP |
|
RGD |
PMID:29691718 |
RGD:14975124 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il18 |
interleukin 18 |
treatment |
IDA IEP |
|
RGD |
PMID:18367607 PMID:23140983 |
RGD:2315889, RGD:8655974 |
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
IEP IDA |
mRNA, protein:increased expression:spinal cord |
RGD |
PMID:16038625 PMID:29691718 PMID:23209732 |
RGD:1626673, RGD:14975124, RGD:7175523 |
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
|
IEP |
mRNA,protein:increased expression:spinal cord |
RGD |
PMID:16456668 |
RGD:7207035 |
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
IDA ISO |
protein:increased expression:serum (human) |
RGD |
PMID:16038625 PMID:17964877 |
RGD:1626673, RGD:6907102 |
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il4 |
interleukin 4 |
|
IMP |
|
RGD |
PMID:20623539 |
RGD:5128562 |
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il4r |
interleukin 4 receptor |
|
IEP |
mRNA:increased expression:spinal cord |
RGD |
PMID:20623539 |
RGD:5128562 |
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
treatment |
IDA IEP |
|
RGD |
PMID:27085942 PMID:29691718 |
RGD:11062150, RGD:14975124 |
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IEP |
|
RGD |
PMID:11723173 |
RGD:2298928 |
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irf5 |
interferon regulatory factor 5 |
treatment |
IEP |
|
RGD |
PMID:24968269 |
RGD:40924652 |
NCBI chr 4:58,127,577...58,140,665
Ensembl chr 4:58,127,640...58,139,267
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
severity |
IEP |
protein:decreased expression:cerebrospinal fluid |
RGD |
PMID:21559420 |
RGD:40907059 |
NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
IMP |
|
RGD |
PMID:23274522 |
RGD:10411896 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
IDA |
protein:increased phosphorylation:neuron |
RGD |
PMID:21132399 |
RGD:4889994 |
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnj10 |
potassium inwardly-rectifying channel, subfamily J, member 10 |
|
IEP |
protein:decreased expression:spinal cord |
RGD |
PMID:20375134 |
RGD:8662905 |
NCBI chr13:84,802,026...84,835,383
Ensembl chr13:84,802,009...84,835,461
|
|
G |
Kcnk2 |
potassium two pore domain channel subfamily K member 2 |
treatment |
IDA |
|
RGD |
PMID:22425721 |
RGD:9831183 |
NCBI chr13:100,766,101...100,963,435
Ensembl chr13:100,766,113...100,963,435
|
|
G |
Kcnn4 |
potassium calcium-activated channel subfamily N member 4 |
|
ISO |
|
RGD |
PMID:24606313 |
RGD:329955563 |
NCBI chr 1:79,956,380...79,974,354
Ensembl chr 1:79,959,322...79,974,340
|
|
G |
Kdm6b |
lysine demethylase 6B |
|
IEP |
mRNA:increased expression:spinal cord (rat) |
RGD |
PMID:22578249 |
RGD:9587821 |
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP |
mRNA:increased expression:spinal cord, astrocyte, macrophage |
RGD |
PMID:17409380 |
RGD:5684414 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kif3b |
kinesin family member 3B |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:23093447 |
RGD:11049594 |
NCBI chr 3:141,758,466...141,798,012
Ensembl chr 3:141,758,466...141,797,963
|
|
G |
Klk6 |
kallikrein related-peptidase 6 |
|
IEP |
protein:increased expression:spinal cord |
RGD |
PMID:16987227 |
RGD:2314866 |
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
|
|
G |
Kmo |
kynurenine 3-monooxygenase |
|
IEP |
mRNA,protein:increased expression:spinal cord: |
RGD |
PMID:26524415 |
|